Skip to main content

Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026)

Company announcement No. 53 / 2026 Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026) Copenhagen, Denmark, October 5, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announces that the share buy-back program (the “Program”) initiated on May 7, 2026 has been completed. The lead manager, Danske Bank, exercised its option to close the Program ahead of October 31, 2026, after the planned aggregate amount of approximately DKK 1,300 million was reached. The Company also reports transactions under the Program for week 40 (September 28 – October 2, 2026) and week 41 (October 5, 2026). The Program was carried out in accordance with Article 5 of...

Continue reading

Announcement of Date of Court Hearing to Sanction the Scheme and Satisfaction of NSIA Condition

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION FOR IMMEDIATE RELEASE 5 October 2026 RECOMMENDED CASH OFFER FOR IRISH CONTINENTAL GROUP, PLC BY BLUEFIN BIDCO LIMITED TO BE IMPLEMENTED BY WAY OF A SCHEME OF ARRANGEMENT UNDER CHAPTER 1 OF PART 9 OF THE COMPANIES ACT 2014 ANNOUNCEMENT OF DATE OF COURT HEARING TO SANCTION THE SCHEME AND SATISFACTION OF NSIA CONDITION On 24 July 2026, the Independent Directors of Irish Continental Group, plc (the Independent ICG Board) and the board of Bluefin Bidco Limited (BidCo) announced that they had agreed the terms of a recommended acquisition (the Acquisition) of the entire issued and to be issued share capital of Irish Continental Group, plc (ICG). ...

Continue reading

SPIE announces the acquisition of Clauser in France

Strengthening SPIE’s position in the strategic fields of industrial maintenance and high-power electrical installationsCergy, 5 October 2026 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the acquisition of 94% of CLAUSER, a family-owned company with recognised expertise in industrial maintenance and high-power electrical installations. Founded in 1963 and based in Saint-Jean-de-Maurienne and Dunkirk, CLAUSER has developed strong expertise over more than 60 years in engineering, modernisation and maintenance services for energy-intensive industrial customers. Its teams are particularly recognised for their longstanding expertise in aluminium production and processing, as well as electrochemical processes. With around 100 employees, CLAUSER generated revenue...

Continue reading

Cerro de Pasco Resources Announces AGM Results

MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (TSXV: CDPR) OTCQX CDPMF) (BVL: CDPR) (“CDPR” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders (the “Meeting”), held on September 30, 2026. A total of 345,835,894 common shares, representing 52.06% of the Company’s issued and outstanding common shares as of the record date, were represented in person or by proxy at the Meeting. All matters submitted to shareholders for approval were approved, namely the election of each director nominee with at least 85% of the votes cast in favour and the appointment of Davidson & Company LLP as the Company’s independent auditors with 100% of the votes cast in favour. Election of Directors Shareholders elected the following eight directors to the Company’s Board...

Continue reading

WEYCO Group, Inc. Third Quarter 2026 Earnings Conference Call

Milwaukee, WI, Oct. 05, 2026 (GLOBE NEWSWIRE) — WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to announce third quarter 2026 financial results after the close on Tuesday, November 3, 2026.  Additionally, Thomas W. Florsheim, Jr., Chairman and CEO, will host a conference call on Wednesday, November 4, 2026, at 11:00 a.m. Eastern Time to discuss the financial results in more detail. To participate in the call, you will first need to pre-register online. Pre-registration takes only a few minutes and you may pre-register at any time, including up to and after the call start time. To pre-register, please go to: https://register-conf.media-server.com/register/BI848ca1b1750c4cf39796a8f3b93fc1a7. The pre-registration process will provide the conference call phone number and a passcode required to enter the call. A...

Continue reading

Independent Research Report about Blue Biofuels Inc., by Harbinger Research

PALM BEACH GARDENS, FL, Oct. 05, 2026 (GLOBE NEWSWIRE) — Blue Biofuels, Inc. (OTCQB: BIOF). Blue Biofuels, Inc. is pleased to announce the publication of a new independent research report by Harbinger Research, LLC, providing an in-depth analysis of the Company, its patented Cellulose-to-Sugar (CTS) technology, and its path toward commercial production. The report, “Patented Cellulosic Fuel Technology Is Advancing from Pilot Development Toward Full Commercial Production,” was prepared by Brian R. Connell, CFA, Senior Research Analyst at Harbinger Research. The report examines Blue Biofuels’ progress as the Company advances from pilot development and Department of Energy-supported scale-up toward integrated demonstration, commercial engineering, project financing, and ultimately commercial construction. It also provides an overview...

Continue reading

Sysco Honored with Southern Smoke Foundation Hall of Flame Award

Recognition celebrates Sysco’s longstanding support of Southern Smoke Foundation and its mission to care for food and beverage industry workersSysco Receives Southern Smoke Foundation Hall of Flame AwardSysco’s April Love, vice president, chief inclusion & community impact officer, and Devin Graves, community impact director, receive the Southern Smoke Foundation Hall of Flame Award from James Beard award-winning chef Chis Shepherd. The foundation recognized Sysco’s longstanding support of food and beverage industry workers through financial contributions and product donations.Sysco Sponsors Southern Smoke Festival 2026Sysco is honored to continue to support hospitality workers as a presenting sponsor of Southern Smoke Festival 2026. Festival proceeds go to the Southern Smoke Foundation Emergency Relief...

Continue reading

Lanterne Dx Completes Merger with Flagship Biosciences, Expanding Biomarker and Digital Pathology Capabilities

Flagship Bioscienceshttps://flagshipbio.com/Ampersand Capital Partnershttps://ampersandcapital.com/Boulder, CO, Oct. 05, 2026 (GLOBE NEWSWIRE) — Lanterne Dx, LLC, a discovery and clinical phase CRO offering histopathology and biomarker validation services to pharmaceutical and biotech customers, today announced it has completed its merger with Flagship Biosciences, Inc., a computational biology, data science, and digital pathology company backed by Ampersand Capital Partners. The combined organization will operate under the Lanterne Dx name. The merger combines Lanterne Dx’s CAP/CLIA-accredited histopathology and biomarker laboratory capabilities with Flagship Biosciences’ expertise in computational pathology, image analysis, and regulatory support. Together, the organizations provide an expanded, integrated platform...

Continue reading

National Advertising Division Finds Blissy Less Frizz Claim Supported; Recommends Certain Other Claims Be Modified or Discontinued

BBB National Programs’ National Advertising Division determined, as part of its routine monitoring program, that Blissy, LLC supported its “Less Frizz” claim for Blissy Silk Pillowcases in context, however, it recommended Blissy modify or discontinue certain claims concerning hair breakage and tangles, anti-aging and wrinkle prevention, acne, clinical study results, and dermatologist endorsements. New York, NY, Oct. 05, 2026 (GLOBE NEWSWIRE) — BBB National Programs’ National Advertising Division determined, as part of its routine monitoring program, that Blissy, LLC supported its “Less Frizz” claim for Blissy Silk Pillowcases in context, however, it recommended Blissy modify or discontinue certain claims concerning hair breakage and tangles, anti-aging and wrinkle prevention, acne, clinical study results, and dermatologist endorsements. Blissy...

Continue reading

PUBLICATION OF 2025 ANNUAL REPORT AND NOTICE OF ANNUAL GENERAL MEETING

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (REGULATION (EU) NO 596/2014). ART SHARE 002 S.A.16, rue E. Ruppert, L-2453 LuxembourgGrand Duchy of LuxembourgR.C.S. Luxembourg B273672LEI: 254900OEKYEX6EFPVO79Ticker: BAC1EUISIN: LU2583605592 For immediate release PUBLICATION OF 2025 ANNUAL REPORT AND NOTICE OF ANNUAL GENERAL MEETING Luxembourg, 5 October 2026 Art Share 002 S.A. (the “Company”), the sole holder of Three Studies for Portrait of George Dyer, 1963 by Francis Bacon, announces that its annual report...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.